Results 251 to 260 of about 2,740,979 (275)
Some of the next articles are maybe not open access.

Chronic Viral and Inflammatory Cardiomyopathy

2006
Overview on Chronic Viral Cardiomyopathy/Chronic Myocarditis.- Unsolved Medical Issues and New Targets for Further Research in Viral Myocarditis and Dilated Cardiomyopathy.- Frontiers in Viral Diagnostics.- Is Virus Persistence a Determinant for Disease Progression?- Parvovirus B19 - The Causative Agent of Dilated Cardiomyopathy or an Harmless ...
openaire   +1 more source

Effect of CBC-Derived Inflammatory Indicators in Predicting Chronic Kidney Disease Risk in Hypertrophic Cardiomyopathy Patients

open access: yesBiomedicines
Background: Hypertrophic cardiomyopathy (HCM) is a prevalent condition that often coexists with chronic kidney disease (CKD), significantly impacting patient prognosis. This study aimed to investigate the predictive value of complete blood cell counts derived inflammatory indicators in assessing CKD risk in HCM patients.
Changying Zhao, Luqin Yan
exaly   +4 more sources

High Leptin and Resistin Expression in Chronic Heart Failure: Adverse Outcome in Patients with Dilated and Inflammatory Cardiomyopathy

European Journal of Heart Failure, 2012
Abstract Aim The expression of leptin and resistin is known to be positively correlated with the incidence of chronic heart failure (CHF). Both adipokines have been implicated in immunomodulation and cardiac remodelling.
Peter, Bobbert   +9 more
openaire   +2 more sources

Abstract 4363716: The efficacy and safety of hydroxychloroquine in patients with chronic inflammatory cardiomyopathy: A multicenter randomized study (HYPIC trial)

Circulation
Introduction: Chronic inflammatory cardiomyopathy (infl-CMP) is a persistent cardiac disorder that often arises from the progression of acute myocarditis. This condition is marked by chronic heart failure, arrhythmias, and reduced quality of life.
Dao Wen Wang, Wu He
openaire   +1 more source

The efficacy and safety of hydroxychloroquine in patients with chronic inflammatory cardiomyopathy after fulminant myocarditis: a multicenter randomized study of the HYPIC trial

European Heart Journal
Abstract Background Chronic inflammatory cardiomyopathy (infl-CMP) is a long-term sequela caused by the chronicity of acute myocarditis, especially fulminant myocarditis (FM). Hydroxychloroquine (HCQ) may benefit these patients by inhibiting the excessive inflammatory response.
W He   +5 more
openaire   +1 more source

Myocarditis and Inflammatory Cardiomyopathy: Current Evidence and Future Directions

Nature Reviews Cardiology, 2021
Carsten Tschöpe   +2 more
exaly  

[Association of the mutations in the human mitochondrial genome with chronic non-inflammatory diseases: type 2 diabetes, hypertension and different types of cardiomyopathy].

Patologicheskaia fiziologiia i eksperimental'naia terapiia, 2013
Genetic predisposition is of great importance among other risk factors of certain socially significant chronic non-inflammatory diseases. Changes in both nuclear and mitochondrial human genome may play a role in the development of these diseases. Recent studies have shown that mutations in the mitochondrial genome are associated with some diseases ...
A V, Zhelankin, M A, Sazonova
openaire   +1 more source

Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy

Circulation: Heart Failure, 2020
Carsten Tschöpe   +2 more
exaly  

Immunosuppressive Therapy in Virus-Negative Inflammatory Cardiomyopathy: 20-Year Follow-Up of the TIMIC Trial

European Heart Journal, 2022
Cristina Chimenti   +2 more
exaly  

Home - About - Disclaimer - Privacy